sad, isn't it?.
i especially love the statement here;.
in recent years many cases and policies have come before the courts and public involving homosexually oriented people and basic civil rights.
Hello Abaddon,
thanks for posting the topic. Quite fascinating..
including the web-link.
Interesting too the panel's composition:
"NARTH, founded in 1992, is composed of psychiatrists,
psychoanalytically informed psychologists, certified
social workers, and other behavioral scientists, as
well as laymen in fields such as law, religion, and education."
Greetings, J.C.MacHislopp
sorry if anyone has already posted this... the latest jw numbers are circulating for the '02-'03 service year.. lands - 235. branches - 109. average publishers - 6,184,046 (2.2% increase.).
peak publishers - 6,429,351 (2% increase).
book placements - 23,273,275 (5.6% increase).
Hello Euphemism,
thanks a lot for the rather anticipated 'news' !!!
I'm also waiting for the rest of the figures, so that I'll also
be able - as Blondie wrote -
to "see what the hidden aspects are of the numbers,
specifically, the MIAs, the difference between the i
ncrease in publishers and the number baptized.
I like to see what the hours look look like compared to
previous years, i.e., while there might be 2.2% increase, t
he average hours per publisher may have dropped. "
Thanks again and greetings,
J.C.MacHislopp
i would like to share with you this ?item?
been organizing tours to branches of the watchtower bible
we are not sponsored by the watchtower bible and tract society.
Hello everyone,
I would like to share with you this ?item? :
http://www.bethelcoachtours.com/
you'll get this:
BETHEL COACH TOURS.com
BCT is an independently owned and operated travel agency that has been organizing tours to branches of the Watchtower Bible and Tract Society worldwide for Jehovah?s Witnesses since 1988. Our goal is to offer trips to our brothers and sisters that are spiritually encouraging, fun, safe, and affordable.
Bethel Coach Tours is not sponsored by the Watchtower Bible and Tract Society.
Bethel Coach Tours ist ein Reisecenter von und für Jehovas Zeugen, deren Freunde und Familien. Wir organisieren und begleiten Reisen zur Weltzentrale der Zeugen Jehovas in New York und zu den verschiedenen Zweigbüros weltweit. Reise mit uns zum Bethel und erfreue Dich einer internationalen Reisegruppe mit Brüdern & Schwestern aus aller Welt! Sieh mit eigenen Augen, wie die Bibel, "Der Wachtturm", "Erwachet!" und viele weitere biblische Literatur hergestellt und versandt wird.
Bethel Coach Tours wird NICHT von der Wachtturm-, Bibel- und Traktatgesellschaft gesponsert.
Bethel Coach Tours es un centro para viajar, por testigo de Jehová, amigos y familieres. Nosotros organizamos viajes accompañados a le central Betel de los Testigos de Jehová en New York y tambien a los otros Betel en el mundo. Viajas con nosotros a la Betel y alegrate de un grupo de ermanos internacional de todo el mundo! Ve con tus ojos, como vienen empremidos las Biblias, "La Atalaya" y "¡Despertad!". Buscamos siempre nuevas ideas para poder tener nuestra web site lo mas effectiva y interessante y tener nuestros viajes actual.
Bethel Coach Tours é un centro viaggi de e per Testimoni di Geova, amici e famigliari. Noi organiziamo viaggi accompergneti alle centrale mondiale dei Testimoni di Geova a New York e ai vari alle filiali nel mondo. Viaggia con noi e rallegrati con un gruppo internazionale di fratelli & sorelle di tutto il mondo! Sie presente come viene stampato la Bibbia, "La Torre di Guardia" e "Svegliatevi!" come altre pubblicazioni. Cerchiamo sempre nuovi methodi per esse attuali nelle nostre pagina web, per presentarvi i viaggi attuali e interessanti.
($$$$$$$$$$$$$$!!!!!)
(Btw, the Italian text is full of ...serious mistakes)
Then visit the next link , in English :
http://www.bethelcoachtours.com/english.htm
Again the disclaimer:
BCT is an independently owned and operated travel agency that has
been organizing tours to branches of the Watchtower Bible
and Tract Society worldwide for Jehovah?s Witnesses since 1988.
Our goal is to offer to our brothers and sisters, their family and
friends trips that are spiritually encouraging, fun, safe and affordable.
We are not sponsored by the Watchtower Bible and Tract Society.
Among the many things , on the web page, you cannot miss this one, so go to
http://www.bethelcoachtours.com/benefits.htm
and read the following ...propaganda:
Bethel Branches All Over The World
There are Bethels with Bethel brothers and sisters all over the world. So when we speak of visiting Bethel we do not necessarily mean just Bethel in NY. A Bethel Vacation could include visiting a Bethel facility anywhere a bethel branch exists.
The Best Vacation on Earth
The best vacation on earth for Jehovah's Witnesses is one that includes a Bethel visit. Seeing how happy everyone is at Bethel as they work hard for Jehovah and for others allows visitors to personally see with their own eyes and feel with their own heart what life in the truth can be like for all of us. It will encourage you to focus not only on your own congregation, but on what Jehovah is doing worldwide through his faithful earthly and heavenly organization. We have seen first hand what a visit to Bethel can do. The tours the Bethel brothers arrange for visitors have the potential to change for the better your view of Jehovah, the organization, and your own congregation forever.
Memories You Can Share with Your Home Congregation
One last point. While the buildings, machines, and procedures you see and learn about are interesting and encouraging, they pale in comparison to the affect the tour guides and the Bethel workers will have on you and the friends traveling with you. You will remember most the attention you receive from the tour guides and the Bethel family. You will be made to feel welcome, loved, and appreciated by the dear brothers who serve at Bethel. You will never forget all the smiles, waves, and hello's that you personally experience. You will adopt the attitude of your bethel guide and the Bethel workers you see on your tours and you will take that attitude back home to your local congregation. Like ripples in a pond, the blessings that come from a visit to Bethel will radiate out through you and touch those with whom you share those precious memories. Now you can see why we believe the best vacation on earth for one of Jehovah's Witnesses includes a visit to Bethel.
Don't forget to browse at the ...schedule !
(All the above information presented on the web page, on the date: October 30th 2003)
I hope you've liked it! : - )
Greetings, J.C.MacHislopp
.
i read today in an economic newspaper that one company named sangart from san diego have solvd the problem to do syntetich blood, the take out fraktions from red bloodsells, as i understand the part how is related to oxigen, the produkt will be on the market inn about 2 year, this must bee very good news fore jw all over the word, so hopfully this problem soon is behind us.. some one here who now more about this?
Hello everyone,
I?m sorry for posting twice the same article. I did really mean to post
this one below:
From : http://news.bbc.co.uk/1/hi/health/3207291.stm
Thursday, 23 October, 2003, 10:11 GMT 11:11 UK
PATIENTS GIVEN ARTIFICIAL BLOOD
Dr Pierre LaFolie, chief physician at the Karolinska Hospital, said that if artificial blood were approved for use it could lead to dramatic changes in health care.
He said: "If this really works all the way, then mankind will have taken a big step forward. This is like landing on the moon."
Dr LaFolie said synthetic blood could save time after an accident - particularly as there is no need test a patient's blood type before administering a transfusion.
Rapid effect
The synthetic blood has also been shown to transport oxygen through the body better than real blood, which can help limit damage to the body, for example during a heart attack.
Dr LaFolie said: "In acute situations time is of the essence, within an hour all these things have to be done.
"That's why I think this artificial blood is so important for people."
The blood would be used to complement a patient's own blood, not replace it, as real blood has qualities that the artificial blood lacks.
The synthetic blood has been developed by researchers in the US - the exact process for developing it has been kept secret - and it has been tested for the first time on eight patients at Karolinska Hospital.
Lead researcher Professor Bengt Fagrell said: "There has been no sign that the blood would be rejected.
"This is a molecule that the body's immune system gladly welcomes."
Professor Fagrell said the patients had been administered artificial blood made out of human red blood cells.
However, he said red blood cells from any mammal could be used.
"We have chosen to use human blood for ethical reasons. But we could use blood within the entire mammal chain, such as cow blood."
Belinda Linden, head of medical information at the British Heart Foundation said: "There is limited availability of fresh blood for transfusion.
"This is due to the short-fall of donors and an increased number of surgical procedures which require blood.
" It is becoming more important to consider safe and effective alternatives.
"There have been previous studies examining the potential of red blood cell substitutes, but this process would need to be evaluated with large groups of people before it is considered for approval."
I do hope that this time, it will be right.
Greetings, J.C.MacHislopp
one of the meanings in the dictionary for the word fraud is:--a deliberate (deception) perpertrated for unlawful or unfair gain.
this is just exactly what jehovah's witnesses tried to do in bulgaria.
the city council adopted a law saying (no places of worship) can be built near schools.
Hello everyone,
Thanks to Voyager for the topic. As he wrote , after the ?famous?
blood compromise/deceitful agreement/WTBS Inc. lie, concerning
Bulgaria, yet another of those sickly actions from representatives
of ..God?s visible organization/channel on earth., did take
place in the same country.
Here below, for all those who didn?t have the time to surf?
t he web page which relates the event:
News
Bigotry Monitor: Volume 3, Number 33
(August 22, 2003)
Volume 3, Number 33
Friday, August 22, 2003
BIGOTRY MONITOR
A Weekly Human Rights Newsletter on Antisemitism, Xenophobia, and Religious Persecution in the Former Communist World and Western Europe
From this link:
http://www.fsumonitor.com/stories/082203Russ2.shtml
and this specific news:
JEHOVAH'S WITNESS CENTER IN BULGARIA MAY BE DEMOLISHED.
A new center the Jehovah's Witnesses are building in Bulgaria?s Black Sea port of Burgas might be destroyed in the wake of popular and city council opposition, according to Forum 18 News Service.
"The city council adopted a law saying no places of worship can be built near schools,? Jehovah's Witness leader Peter Mischler told Forum 18 from the capital Sofia. ?They believe such places will influence children." The new law reportedly grants the council the power to pull down such buildings.
Deputy Mayor Marusya Lyubcheva, responsible for religious affairs, said that the Jehovah's Witnesses had filed papers to build a business center. Upon her discovery that the building would be used for religious meetings, the documents were sent back.
She insists that the city council is acting according to its procedures. "The Jehovah's Witnesses don't have registration with the city administration," she told Forum 18 on August 18. "Religious organizations must have registration to build.? She added: ?Civil society has a problem with this building."
Lyubcheva declined to answer Forum 18's questions about the reported city law barring new places of worship near schools or whether the Jehovah's Witnesses could continue to construct their center.
Mischler acknowledged that the Jehovah's Witnesses secured permission to build an administrative building, but denied that the use of such a building for courses, lectures, and religious meetings violated the law. He also denied that local registration was necessary.
He said: "We already have national re-registration with the Sofia court under the new law, and that is valid for the whole country."
The Jehovah's Witnesses -- who claim 1,300 adherents in Bulgaria ? have faced restrictions on their activity by a number of local authorities in recent years. In Burgas, a temporary tent they had been using was recently pulled down.
Mischler charged that the right-wing IMRO political party has been leading the opposition to the Burgas building. "Basically, they're against all religions other than the Orthodox Church." He said IMRO has organized demonstrations against Islam and other religious communities and initiated ?newspaper articles with lies against us."
Greetings, J.C.MacHislopp
.
i read today in an economic newspaper that one company named sangart from san diego have solvd the problem to do syntetich blood, the take out fraktions from red bloodsells, as i understand the part how is related to oxigen, the produkt will be on the market inn about 2 year, this must bee very good news fore jw all over the word, so hopfully this problem soon is behind us.. some one here who now more about this?
Hello everyone,
Thanks to Happy Man for the latest informations on blood. I?m just adding the
text for those unable to get it.
Notice: All the following informations are taken from " SANGART " home page:
From this link: http://www.sangart.com/
Sangart is a biopharmaceutical company dedicated to improving transfusion practices worldwide.
The company is focused on the research, development, and commercialization of innovative transfusion medicine solutions to the
benefit of all people. Based on pre-clinical studies, Sangart's lead product, Hemospan TM , appears to fulfill the three fundamental requirements for a successful alternative to blood transfusion: efficacy, safety, and affordability.
and this :
http://www.sangart.com/products/
1) Sangart is developing two general classes of hemoglobin-based oxygen carriers, Hemospan TM and Hemospan PS TM . A basic element of the Sangart business strategy is to develop a series of safe and effective oxygen carriers for treatment of blood loss, specific to diverse medical indications.
2)
Hemospan TM combines low hemoglobin concentration with high oxygen transport capability. Hemoglobin is harvested from outdated human blood and combined with PEG to eliminate the toxicity of free hemoglobin. It has been shown in laboratory testing that pegylation of the hemoglobin is an effective shield against immunologic reactions. PEG is used in several pharmaceutical formulations and has extensive safety documentation.
3)
Hemospan PS TM combines Hemospan TM with a volume expander, pentastarch. Hemospan PS TM maintains the potent volume expansion and capillary flow properties of Hemospan TM but requires less hemoglobin for efficacy. Thus its cost will be low, and it may find wider application in markets where cost is limiting. Pentastarch is approved for human use in many countries throughout the world and has extensive safety documentation.
4)
Special formulations are being developed for military and disaster applications. Sangart is also working on novel methods to prepare SFH and Hemospan TM . Sangart believes that these methods will eliminate substantially the need to build big, complex factories to handle blood processing for manufacture into Hemospan TM and will therefore extend the Hemospan TM family of products into markets that are now underserved by transfusion medicine practices.
F.AQ.
1. How much research and development have gone into Sangart's products and approaches?
The research that has culminated in formation of Sangart began in 1985 in the U.S. Army's Blood Research Division in San Francisco. In the 6 years that Dr. Winslow directed that program, approximately $17 million was invested in in-house and contract research. A 5-year NIH-supported Program Project Grant provided an additional $4 million, approximately. Therefore, the total investment has been over $20 million. In contrast to industry-sponsored research, this entire program has been rigorously reviewed at every stage by our peers, and the program has contributed well over 100 original, peer-reviewed publications related to blood substitutes and hundreds of additional publications, books and reviews on related subjects.
2. What are the key discoveries that have led to Sangart's products?
The physiology of oxygen transport by cell-free hemoglobin has been a multidisciplinary effort involving physical chemistry, physiology and microcirculation studies. New methods were developed, as a part of our research program, for measuring the physical properties of hemoglobin solutions, including oxygen binding, and for measuring oxygen in highly focused areas inside vessels. The diffusive properties of hemoglobin molecules were discovered using artificial capillary instrumentation invented in our laboratory. Clinically realistic animal models were utilized to test the new theories and to verify that the new formulations perform as predicted.
3. What are the pharmacoeconomics of Sangart's products?
This is a very exciting aspect of Sangart's approach. Because the product is designed and optimized for oxygen delivery, even a very small amount is effective in animals. Most commercial products currently require 2 units of donor blood for each unit of product. Sangart's process will deliver 3-5 units of product for each unit of donor blood used as raw material. This is a 10-fold gain in efficiency compared to existing products. Since the major cost of donor blood lies in testing, the cost savings will be even more than 10-fold. A precise analysis of the final cost of Sangart's product is proprietary, but certain products are designed to be cost-competitive with donor blood.
4. Why will Sangart's product be successful, when the competing products have all been disappointing?
In 1992, Dr. Winslow's book, Hemoglobin-based Red Cell Substitutes, summarized the current understanding of these products, including the provisional recommendation that a successful product should have 1) low viscosity, 2) low oncotic pressure and 3) oxygen affinity similar to that of blood. The competing companies fixed the characteristics of their products prior to that time. The research program, begun at Letterman Army Institute of Research and continued at UCSD, was aimed at testing these recommendations. Thirteen years of public, peer-reviewed research have shown that each of the assumptions was incorrect. This research was only possible because it was not aimed at developing any particular product, rather at understanding underlying mechanisms. In addition, Dr. Winslow's group was in the unique position to test and compare hemoglobins which represent each of the classes of commercial products. The counterintuitive conclusions reached by the group are being accepted in the scientific community, but slowly. This has created for Sangart a window of opportunity to introduce and develop novel products that not only function in biological systems, but will have substantially lower cost because they deliver oxygen in optimal, clearly understood ways.
5. Why don't competing products deliver oxygen in the way that Sangart's does?
We have shown that sizes of some of the competitors' molecules are too small and their viscosities are too low to be effective oxygen carriers. Consequently, these products deliver their oxygen to vessel walls, producing vasoconstriction which consumes oxygen and prevents it from reaching tissues where it is needed.
6. Does Sangart's product pick up CO2 as well as deliver O2?
Yes. In fact, we are the only group that has studied this problem. Our new instrumentation (the artificial capillary) has allowed us to make direct measurements of CO2 pickup and release.
7. Does Sangart's product circulate long enough to be of practical use?
PEG-modified hemoglobins have the longest known circulating half-times (a half-time is the time at which one-half of the administered dose is still present in the circulation). In general, intramolecular-crosslinks lead to 12 hour half-time, polymerizations lead to 20 hour half-times. Based on experiments in animals, we anticipate half-times in excess of 2 days. Theoretical considerations have led us to believe that this half-time is long enough to allow the body to replace a substantial part of lost red cells on its own.
"Blood shortages, once a seasonal threat, have become year-round crises in many parts of the country, disrupting surgical schedules and forcing hospitals to make precarious treatment decisions." - Los Angeles Times , July 15th 2001
"More than two-thirds of the world's nations are failing to supply safe blood to their populations. Their failure adds significantly to the spread of the virus that causes AIDS as well as potentially deadly forms of hepatitis and other diseases." - The New York Times, July 4th, 2000
"All donated blood undergoes strict testing; even so, of the nation's 12 million units of donated blood, about 10 H.I.V. infected units are undetected each year, causing about two or three H.I.V. infections annually." - The New York Times, 9/15/00
"For the first time, the government is starting a day-to-day tracking system to monitor the nation's blood supply and sound an alarm when shortages loom." - San Diego Union Tribune, August 21, 2001
"Artificial blood would be a blessing." --Bernadine Healy, President, American Red Cross, March 4, 2001
"There are striking disparities in the safety and availability of blood among nations with high, medium, and low human development indices. Problems include limited availability of donors, laboratory supplies, inappropriate use of scarce resources and weakness or lack of national blood transfusion services and standards." -- Dr. Jean Emmanuel, Director of Blood Safety and Clinical Technology at the World Health Organization
"Amoung the obstacles to establish modern blood technology in developing countries are the lack of self-sufficiency, unsustainable supplies of reagents and tests, inadequate regulation of blood products, no plans for recruitment of volunteer donors, insufficient funds, and lack of training for staff." --Dr. Mohammed El-Nageh, International Consortium for Blood Safety
"The prevelance of transfusion-transmissible disease in a developing country is roughly 100 times in the donor population compared to the developed world. The smaller size of blood banks and the absence of health insurance in developing countries are an immediate constraint against expensive safety measures." --Dr. Jean-Piere Alain
"Some rural communities in China have some of the highest localized rates of HIV infection in the world: some say 20 percent." --Elisabeth Rosenthal, New York Times, October 28, 2000
"In most developing countries there are small, private markets for safe blood that meets the highest standards, but these comprise only about 10 percent of the total market." --Dr. Rajen Dalal
Analysis of air and blood samples from the summit of Mount Everest in 1981 required construction of specialized equipment that could be carried in a back pack and which could be powered by batteries or solar panels. This work led to development of instruments and techniques that were critical to the development of Hemospan TM .
Some anthropological groups, such as this Sherpa of the Himalaya, can withstand life-long exposure to low oxygen without apparent permanent effects. Other groups which have not resided as long at altitude, such as South American Indians, develop severe problems. Some researchers believe that Sherpas have undergone genetic adaptation to high altitude life.
Collection of expired (alveolar) air on the summit of Mount Everest in 1981 allowed analysis of the delivery of oxygen by red cells which was one the the first clues that in some conditions it may be more desirable for the red cells to bind oxygen more avidly, rather than less, in order to absorb adequate amounts of oxygen in the lungs. This work led to the formulation of the hypotheses which were critical to the theoretical basis of Hemospan TM development.
The study of high altitude residents of South America with "Chronic Mountain Sickness" (or Monge's disease) has been valuable in understanding the way in which normal red cells deliver oxygen as well as how the body regulates its red cell production.
"Last year, the tally of blood transfusions climbed to a record high. More people are donating blood than ever before, but a rapidly aging society is using it up even faster as the number of elective surgeries and medical treatments requiring blood transfusions continues to rise." - Science News, Volume 159, 3/31/01
Btw, the latest is that a group of physicians , in Stockholm, is working to produce
artificial blood that will change from powder state to liquid form.
Greetings, J.C.MacHislopp
http://www.miami.com/mld/miamiherald/7100394.htm
posted on sat, oct. 25, 2003 .
dying mother can rest easy.
Hello Nathan Natas,
Thanks for sharing with us this rather sad news item.
It really shows the true colours of ?WTBS Inc. in
general and how ?quick the ?true Christian? are
forgetting the great command: .. Love your ..fellow man?
Thanks also for the link.
Greatings, J.C.MacHislopp
comments you will not hear at the 10-26-03 wt study
wt quotes will be in
he wrote: "whatever things are true, whatever things are of serious concern, whatever things are righteous, whatever things are chaste, whatever things are lovable, whatever things are well spoken of, whatever virtue there is and whatever praiseworthy thing there is, continue considering these things.
Hello Blondie,
I wish to congratulate you for the excellent piece of work.
Your comments are true, your research commendable and useful.
It is a real pleasure to read you 'review', which very cleverly and in a
logical way show extremely well the double talk of the mighty WTBS Inc.
Btw, I really appreciate the research conncerning the complete quote on
' the gift of speech' and all the quotes about ...the 'elders'!
Thanks again, and keep well, you and your family
Greetings,
James Charles MacHislopp
* quote from the year
quote from the year
* quote from the year
Hello everyone,
these few lines to thanks you for the nice comments.
Mizpah:
Thanks also for the appreciative remarks. I do agree with you
also on this point:
"The 1914 date is now getting embarrassing for them to explain.
But it remains crucial to its whole system of belief in the "faithful and
discreet slave" class. "
Greven
Thanks for the appreciative remarks and most of all for the
concise and factual answer to Happy Man. I do believe that
thsi part is very important:
"They taught at least until 1930 that the parousia had taken place in 1874.
In 1930 Rutherford changed this to 1914 but gave no explanation for this
change no change of chronology was presented. Between 1930 and
1942 they are mostly silent on this topic and explain in 1942 why
with chronology changes. "
Happy Man:
Thanks for taking the time to read the topic and also for your
comments. I do believe that Greven has given you a very nice ,
truthful, factual and well written answer.
Please allow me give yu some small reminders:
1st :
*** w54 6/15 p. 370 The Revelation of Jesus Christ ***
4 "Why, then, do the nations not realize and accept the approach of this climax of judgment? It is because they have not heeded the world-wide advertising of Christ's return and his second presence. Since long before World War I Jehovah's witnesses pointed to 1914 as the time for this great event to occur . And since 1914 physical evidences establishing this truth have been pointed to repeatedly in the columns of The Watchtower. ?
Please notice also the subtle association :
***Since long before World War I Jehovah's witnesses..."
Now World War I was fought between 1914 and 1918 , so If I declare that:
"...Since long before ..." Well you know very well the answer.
Never Charles Taze Russell nor any of the Bible Students, pointed to the year
1914 as the time for this great event to occur i.e.
"Christ's return and his second presence.."
for the simple fact that they were preaching worldwide
since 1877, that the event took place in the
year 1874!
2nd :
Quote from the book:
"JEHOVAH'S WITNESSES IN THE DIVINE PURPOSE "
(chapter 15 th , page 10i and 102 )
"...At Cedar Point,Ohio,an international convention was held,September 5-13,1922.
...
Emphasizing the theme of the Kingdom,Brother Rutherford delivered a
historic lecture on the subject :"The Kingdom".
"He said :
Why has the King come?To set up [God's ]
kingdom and reign as King .But he had a work to do before his reign began,and that is a preparatory work.Since there are to be asso- ciated with him in his reign his body members, these must be gathered together and prepared for the beginning of the reign ....
...from all others,standing as his witnesses,fear- lessly crying out the message :
"The kingdom of heaven is at hand!"...
Do you believe it?
Do you believe that the King of glory is present, and has been since 1874?
Do you believe that during that time he has conducted his harvest work?
Do you believe that he has had during that time a faithful and wise servant through whom he directed his work and the feeding of the household of faith?"
Furthermore, you are also familiar with the fact that the name change ,
from Bible Students , to " Jehovah's Witnesses " took place in the year
1931... i.e. 13 years after the end of Wold War I ! -
So you have to admit that ... the subtle association , in the same phrase
and even in the same line:
"Since long before World War I Jehovah's witnesses..."
is quite inaccurate and truly...misleading!
3rd:
From the book:
« Isaiah?s Prophecy ? Light for all Mankind - Volume II «
published in the year 2001
*** ip-2 chap. 28 pp. 408-410 A Light for the Nations ***
14 Does this prophecy have a modern-day fulfillment? Yes, indeed.
Following World War I, Jehovah?s anointed servants discerned from the
Scriptures that God?s Kingdom had been set up in heaven in 1914.
Through careful Bible study, they learned that additional Kingdom heirs, or ?brothers,? were to be gathered. Intrepid ministers traveled to ?the most distant part of the earth,? using all manner of conveyance, in search of prospective members of the anointed remnant, most of whom came out of Christendom?s churches. When these were located, they were brought in as a gift to Jehovah.?Acts 1:8.
I don't really understand your comment:
" ... one thing, in the Issaja book site 409, p 14 ,you dont tell what it is said, it is like this," AFTER first word war understand Jehovas servants widh help from the bibel that jehovas kingdom take power in 1914"
Because I did take the quote directly from the WTBS Inc. CD and also , as I have already written before, the quote was part of the material , for the ? worldwide - congregation?s book study , beginning on Monday, October 13th , 2003 .-
I do hope that these few lines will be helpful to you. As a matter of fact the WTBS Inc. wrote :
*** w87 3/1 14-15 'Upon the Watchtower I Am Standing' ***
18 To this day the Governing Body follows similar guidelines.
Each article in both The Watchtower and Awake! and every page, including the artwork, is scrutinized by selected members of the Governing Body before it is printed.
Furthermore, those who assist in writing articles for The Watchtower are Christian elders who appreciate the seriousness of their assignment. (Compare 2 Chronicles 19:7.)
They spend many hours in researching the Bible and other reference material to make sure that what is written is the truth and that it faithfully follows the Scriptures. (Ecclesiastes 12:9, 10; 2 Timothy 1:13)
and also this:
*** w95 5/15 22-3 Flashes of Light-Great and Small (Part 2) ***
As shown in the 1977 Yearbook of Jehovah?s Witnesses (pages 258-9), in 1976 the Governing Body began to function with six committees, each assigned to care for certain aspects of the worldwide work.
The Writing Committee supervises the preparation and translation of publications in all forms , making sure that everything is in line with the Scriptures.
In conclusion and as very personal statement I do really agree 100%
with the following:
from ' The Watchtower ' August 1st, 2003 pages 15-16 § 8-10 :
Jehovah's Servants Are Truthful
....
Paul counseled fellow believers: "Speak truth each one of you with his neighbor; because we are members belonging to one another." (Ephesians 4:25)
To many, lying may seem a convenient tool to obtain certain advantages. People lie to escape punishment, to profit in some way, or to gain the praise of others.
Yet, a practice of lying is a vice. What is more, a liar cannot gain God's approval.
When we are known to be truthful, others believe what we say; they trust us.
However, if we are caught telling even a single lie, others may doubt the truthfulness of anything we say in the future.
An African proverb states: "One falsehood spoils a thousand truths."
Another proverb says: "A liar will not be believed, even when he speaks the truth."
°°°°°°°°°°°°°°°°°°°°°°°
The material was part of " The Watchtower " Study, scheduled worlwide, for Sunday, September 14th 2003 )
Thanks again.
Greetings, J.C.MacHislopp
"In silvam non ligna feras insanius " (Oratio, Satire, I, 10, 34)
P.S. Greven I?ve just seen your new addition. I'll comment on it later. Many, many thanks in advance. JCMacH
.
i read today in an economic newspaper that one company named sangart from san diego have solvd the problem to do syntetich blood, the take out fraktions from red bloodsells, as i understand the part how is related to oxigen, the produkt will be on the market inn about 2 year, this must bee very good news fore jw all over the word, so hopfully this problem soon is behind us.. some one here who now more about this?
Hello Happy man,
Thanks for the latest update on Blood researches.
Excellent stuff and very logical comments.
Please , allow me to add the following in behalf
of all those with very little time to spare in long
researches on the web.
Notice: All the following informations are taken from " SANGART " home page:
From this link: http://www.sangart.com/
Sangart is a biopharmaceutical company dedicated to improving transfusion practices worldwide.
The company is focused on the research, development, and commercialization of innovative transfusion medicine solutions to the
benefit of all people. Based on pre-clinical studies, Sangart's lead product, Hemospan TM , appears to fulfill the three fundamental requirements for a successful alternative to blood transfusion: efficacy, safety, and affordability.
and this :
http://www.sangart.com/products/
1) Sangart is developing two general classes of hemoglobin-based oxygen carriers, Hemospan TM and Hemospan PS TM . A basic element of the Sangart business strategy is to develop a series of safe and effective oxygen carriers for treatment of blood loss, specific to diverse medical indications.
2)
Hemospan TM combines low hemoglobin concentration with high oxygen transport capability. Hemoglobin is harvested from outdated human blood and combined with PEG to eliminate the toxicity of free hemoglobin. It has been shown in laboratory testing that pegylation of the hemoglobin is an effective shield against immunologic reactions. PEG is used in several pharmaceutical formulations and has extensive safety documentation.
3)
Hemospan PS TM combines Hemospan TM with a volume expander, pentastarch. Hemospan PS TM maintains the potent volume expansion and capillary flow properties of Hemospan TM but requires less hemoglobin for efficacy. Thus its cost will be low, and it may find wider application in markets where cost is limiting. Pentastarch is approved for human use in many countries throughout the world and has extensive safety documentation.
4)
Special formulations are being developed for military and disaster applications. Sangart is also working on novel methods to prepare SFH and Hemospan TM . Sangart believes that these methods will eliminate substantially the need to build big, complex factories to handle blood processing for manufacture into Hemospan TM and will therefore extend the Hemospan TM family of products into markets that are now underserved by transfusion medicine practices.
F.AQ.
1. How much research and development have gone into Sangart's products and approaches?
The research that has culminated in formation of Sangart began in 1985 in the U.S. Army's Blood Research Division in San Francisco. In the 6 years that Dr. Winslow directed that program, approximately $17 million was invested in in-house and contract research. A 5-year NIH-supported Program Project Grant provided an additional $4 million, approximately. Therefore, the total investment has been over $20 million. In contrast to industry-sponsored research, this entire program has been rigorously reviewed at every stage by our peers, and the program has contributed well over 100 original, peer-reviewed publications related to blood substitutes and hundreds of additional publications, books and reviews on related subjects.
2. What are the key discoveries that have led to Sangart's products?
The physiology of oxygen transport by cell-free hemoglobin has been a multidisciplinary effort involving physical chemistry, physiology and microcirculation studies. New methods were developed, as a part of our research program, for measuring the physical properties of hemoglobin solutions, including oxygen binding, and for measuring oxygen in highly focused areas inside vessels. The diffusive properties of hemoglobin molecules were discovered using artificial capillary instrumentation invented in our laboratory. Clinically realistic animal models were utilized to test the new theories and to verify that the new formulations perform as predicted.
3. What are the pharmacoeconomics of Sangart's products?
This is a very exciting aspect of Sangart's approach. Because the product is designed and optimized for oxygen delivery, even a very small amount is effective in animals. Most commercial products currently require 2 units of donor blood for each unit of product. Sangart's process will deliver 3-5 units of product for each unit of donor blood used as raw material. This is a 10-fold gain in efficiency compared to existing products. Since the major cost of donor blood lies in testing, the cost savings will be even more than 10-fold. A precise analysis of the final cost of Sangart's product is proprietary, but certain products are designed to be cost-competitive with donor blood.
4. Why will Sangart's product be successful, when the competing products have all been disappointing?
In 1992, Dr. Winslow's book, Hemoglobin-based Red Cell Substitutes, summarized the current understanding of these products, including the provisional recommendation that a successful product should have 1) low viscosity, 2) low oncotic pressure and 3) oxygen affinity similar to that of blood. The competing companies fixed the characteristics of their products prior to that time. The research program, begun at Letterman Army Institute of Research and continued at UCSD, was aimed at testing these recommendations. Thirteen years of public, peer-reviewed research have shown that each of the assumptions was incorrect. This research was only possible because it was not aimed at developing any particular product, rather at understanding underlying mechanisms. In addition, Dr. Winslow's group was in the unique position to test and compare hemoglobins which represent each of the classes of commercial products. The counterintuitive conclusions reached by the group are being accepted in the scientific community, but slowly. This has created for Sangart a window of opportunity to introduce and develop novel products that not only function in biological systems, but will have substantially lower cost because they deliver oxygen in optimal, clearly understood ways.
5. Why don't competing products deliver oxygen in the way that Sangart's does?
We have shown that sizes of some of the competitors' molecules are too small and their viscosities are too low to be effective oxygen carriers. Consequently, these products deliver their oxygen to vessel walls, producing vasoconstriction which consumes oxygen and prevents it from reaching tissues where it is needed.
6. Does Sangart's product pick up CO2 as well as deliver O2?
Yes. In fact, we are the only group that has studied this problem. Our new instrumentation (the artificial capillary) has allowed us to make direct measurements of CO2 pickup and release.
7. Does Sangart's product circulate long enough to be of practical use?
PEG-modified hemoglobins have the longest known circulating half-times (a half-time is the time at which one-half of the administered dose is still present in the circulation). In general, intramolecular-crosslinks lead to 12 hour half-time, polymerizations lead to 20 hour half-times. Based on experiments in animals, we anticipate half-times in excess of 2 days. Theoretical considerations have led us to believe that this half-time is long enough to allow the body to replace a substantial part of lost red cells on its own.
"Blood shortages, once a seasonal threat, have become year-round crises in many parts of the country, disrupting surgical schedules and forcing hospitals to make precarious treatment decisions." - Los Angeles Times , July 15th 2001
"More than two-thirds of the world's nations are failing to supply safe blood to their populations. Their failure adds significantly to the spread of the virus that causes AIDS as well as potentially deadly forms of hepatitis and other diseases." - The New York Times, July 4th, 2000
"All donated blood undergoes strict testing; even so, of the nation's 12 million units of donated blood, about 10 H.I.V. infected units are undetected each year, causing about two or three H.I.V. infections annually." - The New York Times, 9/15/00
"For the first time, the government is starting a day-to-day tracking system to monitor the nation's blood supply and sound an alarm when shortages loom." - San Diego Union Tribune, August 21, 2001
"Artificial blood would be a blessing." --Bernadine Healy, President, American Red Cross, March 4, 2001
"There are striking disparities in the safety and availability of blood among nations with high, medium, and low human development indices. Problems include limited availability of donors, laboratory supplies, inappropriate use of scarce resources and weakness or lack of national blood transfusion services and standards." -- Dr. Jean Emmanuel, Director of Blood Safety and Clinical Technology at the World Health Organization
"Amoung the obstacles to establish modern blood technology in developing countries are the lack of self-sufficiency, unsustainable supplies of reagents and tests, inadequate regulation of blood products, no plans for recruitment of volunteer donors, insufficient funds, and lack of training for staff." --Dr. Mohammed El-Nageh, International Consortium for Blood Safety
"The prevelance of transfusion-transmissible disease in a developing country is roughly 100 times in the donor population compared to the developed world. The smaller size of blood banks and the absence of health insurance in developing countries are an immediate constraint against expensive safety measures." --Dr. Jean-Piere Alain
"Some rural communities in China have some of the highest localized rates of HIV infection in the world: some say 20 percent." --Elisabeth Rosenthal, New York Times, October 28, 2000
"In most developing countries there are small, private markets for safe blood that meets the highest standards, but these comprise only about 10 percent of the total market." --Dr. Rajen Dalal
Analysis of air and blood samples from the summit of Mount Everest in 1981 required construction of specialized equipment that could be carried in a back pack and which could be powered by batteries or solar panels. This work led to development of instruments and techniques that were critical to the development of Hemospan TM .
Some anthropological groups, such as this Sherpa of the Himalaya, can withstand life-long exposure to low oxygen without apparent permanent effects. Other groups which have not resided as long at altitude, such as South American Indians, develop severe problems. Some researchers believe that Sherpas have undergone genetic adaptation to high altitude life.
Collection of expired (alveolar) air on the summit of Mount Everest in 1981 allowed analysis of the delivery of oxygen by red cells which was one the the first clues that in some conditions it may be more desirable for the red cells to bind oxygen more avidly, rather than less, in order to absorb adequate amounts of oxygen in the lungs. This work led to the formulation of the hypotheses which were critical to the theoretical basis of Hemospan TM development.
The study of high altitude residents of South America with "Chronic Mountain Sickness" (or Monge's disease) has been valuable in understanding the way in which normal red cells deliver oxygen as well as how the body regulates its red cell production.
"Last year, the tally of blood transfusions climbed to a record high. More people are donating blood than ever before, but a rapidly aging society is using it up even faster as the number of elective surgeries and medical treatments requiring blood transfusions continues to rise." - Science News, Volume 159, 3/31/01
°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°°
That?s all.
Greetings, J.C.MacHislopp
